F Alpizar1. 1. Department of Obstetrics and Gynecology, Hospital San Rafael, Alajuela, Costa Rica. falpizar@bytecr.com
Abstract
OBJECTIVES: To evaluate the safety, efficacy and acceptability of quinacrine sterilization (QS) in Costa Rica. METHODS: From 1989 though August 1993, 694 women volunteered for QS in my private practice. All were referred by a family planning clinic or a local hospital obstetric service. The protocol used involved the transcervical insertion of 216 mg of quinacrine hydrochloride in the form of 6 pellets. A second dose was given 4 weeks later. All insertions were done in the first 14 days of the menstrual cycle. The procedure was similar to the CuT IUD placement. Temporary contraception was recommended for 3 months after the last insertion. The cut-off date for this analysis was April 1994. RESULTS: With 7 months to 5 years of follow-up, the gross pregnancy rate was 2.5%. Side effects were relatively minor, none requiring hospitalization. CONCLUSION: QS was found to be safe, effective and acceptable.
OBJECTIVES: To evaluate the safety, efficacy and acceptability of quinacrine sterilization (QS) in Costa Rica. METHODS: From 1989 though August 1993, 694 women volunteered for QS in my private practice. All were referred by a family planning clinic or a local hospital obstetric service. The protocol used involved the transcervical insertion of 216 mg of quinacrine hydrochloride in the form of 6 pellets. A second dose was given 4 weeks later. All insertions were done in the first 14 days of the menstrual cycle. The procedure was similar to the CuT IUD placement. Temporary contraception was recommended for 3 months after the last insertion. The cut-off date for this analysis was April 1994. RESULTS: With 7 months to 5 years of follow-up, the gross pregnancy rate was 2.5%. Side effects were relatively minor, none requiring hospitalization. CONCLUSION:QS was found to be safe, effective and acceptable.
Authors: Jeffrey T Jensen; Carol Hanna; Shan Yao; Elizabeth Micks; Alison Edelman; Lindsay Holden; Ov D Slayden Journal: Contraception Date: 2013-11-26 Impact factor: 3.375
Authors: Jeffrey T Jensen; Carol Hanna; Shan Yao; Cassondra Bauer; Terry K Morgan; Ov D Slayden Journal: Contraception Date: 2015-06-09 Impact factor: 3.375